When you have Alpha-1, your body’s defenses against lung and liver diseases are down. While these lifestyle changes cannot cure Alpha-1, they can reduce the impact of low-AAT on your body.
Smoking increases the amount of neutrophil elastase in your lungs and may speed up the progression of lung damage. Quitting may not be easy, but it may be done. Don’t give up if your first attempt to stop smoking fails. Keep trying and chances are you will be successful. Discuss therapeutic and behavior modification programs with your doctor.7
Second-hand smoke is dangerous if you have Alpha-1. If someone in your household smokes, ask them to stop, or step outside when smoking, or avoid them when they smoke.7
If you live in the United States, call the American Lung Association (800-LUNG-USA, 800-586-4872) or get more information about quitting on their Web site.
Prevent infections and treat them aggressively. Your body responds to infection by producing white blood cells that release neutrophil elastase, which can damage your lungs. Call your doctor at the earliest signs of cold or flu. Follow your doctor's advice for appropriate treatment. Ask about vaccines for flu and pneumonia. Avoid contact with people with colds. Washing your hands helps.7
Avoid environmental pollutants, both at home and in the workplace, if possible.
Good nutrition helps maintain lung function 3 ways:
Because your body breaks down different nutrients in different ways, lung disease produces a lot of CO2 in your bloodstream. This leads to weakness in your diaphragm and other breathing muscles, which leads to respiratory failure . The goal is to decrease foods that produce CO2 and the resulting demand on your lungs.1
There are several guidelines that are common for people with Alpha-1:
Consult your doctor or a registered dietitian before making any dietary changes.
Weight loss is a common problem for people with chronic lung diseases such as Alpha-1; up to 40% of people with Alpha-1 have progressive weight loss . One theory is that people with Alpha-1 take in fewer calories. Another idea is that people with Alpha-1 burn more calories because they use more energy breathing. What may be enough for a person with normal lung function may not be enough for a person with Alpha-1.1
While it’s important to eat enough, eating too much can add to the burden on your lungs. Strike a balance between energy needs and food intake.
Consult with your doctor or registered dietician if you lose or gain weight for recommendations about maintaining your proper weight.
Routine exercise helps improve mental outlook, stamina, and physical well-being. The long-term benefits are significant.1,2
Discuss your goals with your doctor, trainer, or exercise physiologist, and tailor an exercise program to your needs. Many people find that simple, routine stretching exercises, walking, or bicycling improves exercise tolerance.
The key to success is to follow the regimen that has been designed for you.
The right amount of exercise is different for each individual depending on your physical well-being and lung function. Start with low-intensity activity such as walking. Chart out a plan and keep a record of your exercise. After 3 to 4 weeks, you should see progress. Set realistic goals and refine them as your tolerance and stamina improve.1,2
Managing stress may help you feel better and avoid adverse effects on your health. Stress management may offer benefits such as improved breathing, reduced shortness of breath, and relief of anxiety through relaxation techniques. 7
Breathing exercises and muscle relaxation are common ways to relieve stress. Other techniques include biofeedback, visualization, hypnosis, systematic desensitization, positive thinking, and yoga.
Talk to your doctor for more information on specific techniques. The following is a brief summary of stress management techniques:7,8
A Guide for the Individual Recently Diagnosed With Alpha-1
Prolastin-C, Alpha1-Proteinase Inhibitor (Human) is for adults who have emphysema caused by inherited alpha1-antitrypsin deficiency. The effect of therapy with any alpha1-proteinase inhibitor (alpha1-PI) on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials. PROLASTIN-C is not indicated as therapy for lung disease in patients in whom severe Alpha1-PI deficiency has not been established.
Prolastin-C may contain trace amounts of IgA. IgA deficient patients with antibodies against IgA should not receive Prolastin-C due to the risk of hypersensitivity.
The most common side effects during clinical trials with Prolastin-C were chills, a general feeling of being unwell, headache, rash, hot flush, and itching.
Prolastin-C is made from human plasma. Products made from human plasma may carry a risk of transmitting infectious agents, e.g., viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.
Please see accompanying Prolastin-C Full Prescribing Information for complete prescribing details.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.